Today at US HUPO, our SVP of Commercial, Baljit Ubhi, will present a poster titled "Absolute Quantitation of Metabolites in Murine Blood Plasma Using Machine Learning: A Step Towards Generalizing to Untrained Analytes. " The poster highlights our work with the Kanarek Lab at Boston Children's Hospital.
Matterworks
Biotechnology Research
Somerville, MA 1,368 followers
AI for the Language of Biochemistry
About us
Matterworks is using the power of AI to fundamentally change the impact of biological measurements and observations.
- Website
-
https://www.matterworks.ai
External link for Matterworks
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Somerville, MA
- Type
- Privately Held
Locations
-
Primary
Somerville, MA, US
Employees at Matterworks
Updates
-
#Pittcon is taking place in Boston for the first time & we're excited to participate! Our technology is being presented in the main program, and we'll be on the exhibition floor at booth 1835. Come and hear about our AI-powered technology for raw LC-MS data interpretation.
-
-
It's that time of the year already — time to submit #ASMS abstracts! 📄 We're honored to work with such great customers and collaborators for this year's ASMS conference and can't wait to share what we've been hard at work on. #ASMS2025 #teammassspec
-
-
Be sure to find us at US HUPO later this month. Baljit Uhbi will be presenting a poster on Monday (Poster P11.05B) and Mel Hernandez on Tuesday (Poster P11.06LB).
-
-
Metabolic flux analysis (MFA) presents some major analytical challenges, yet it can play a pivotal role in biopharmaceutical development. How do we streamline this process? Read the BioPharm International interview with Dr. Sam Yenne from Metalytics Inc. to explore how machine learning revolutionizes MFA. Download a copy here: https://hubs.la/Q035dhYc0 #MetabolicFlux #Biopharma #MachineLearning #Innovation #Metabolomics
-
Catch Baljit Ubhi and Mel Hernandez at US HUPO later this month, where they will be presenting two posters: 1️⃣ Absolute Quantitation of Metabolites in Murine Blood Plasma Using Machine Learning: A Step Towards Generalizing to Untrained Analytes to be presented Monday, February 24 (Poster Number P11.05LB) 2️⃣ High Throughput Metabolite Quantification in Biological Samples with Pyxis, a Matrix-Agnostic AI/ML Tool to be presented Tuesday, February 25 (Poster Number P11.06LB) We look forward to a week of engaging discussions and networking!
-
-
We're looking forward to #Pittcon2025! Meet with members of our team at booth #1853 and hear more about machine-learned annotation of raw mass spec data. Also be sure to attend the presentation by our CSO, Dr. Jennifer Campbell: "Using AI to enable rapid decision making by transforming raw LC-MS data to identified and quantified molecules" https://hubs.la/Q034lJ_C0
-
-
🎙 Listen to our podcast featuring Dr. Sam Yenne of Metalytics Inc., a company that specializes in the science of metabolic flux. Metalytics has recently assessed and adopted Pyxis, a new tool for absolute quantitation of raw LC-MS data. In this podcast he describes MFA, its utility in biopharmaceutical development, associated challenges and how Pyxis impacts those challenges. https://hubs.la/Q03320fr0
Bringing Scalability to Metabolic Flux Analysis Using Machine Learning to Accelerate LC-MS Interpretation
biopharminternational.com
-
Matterworks reposted this
I am excited to attend #JPM2025 with my colleagues Baljit Ubhi, Ph.D. and Jack (J.M.) Geremia, PhD. My focus for the meeting is to discuss our predictive modeling capabilities using our proprietary LSM foundation model. We have shown predictability in biopharma, microbiome, health and beauty and other products. Let's meet to discuss how we can speed up your drug development efforts. This year I will be hosting meetings at the Golden Gate Yacht Club and the Hilton in conjunction with the Bullpen (https://lnkd.in/eKfAEyJx). See you all soon!
Matterworks SVP of Business Development, Mel Hernandez is looking forward to attending JPM 2025. Connect with Mel to learn how our AI-based approach to predictive biology can enable deeper insights to the molecular underpinnings of complex biological therapies - from monoclonal antibodies to ADCs and even cell & gene therapies. Please reach out to Mel Hernandez via LinkedIn to schedule time during JPM 2025.
-